Whole pancreas removal with islet transplant for high-risk pancreatic tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a surgery that removes the whole pancreas and then puts your own insulin-making cells back into your liver. It is for people with certain types of pancreatic or nearby tumors who also have a soft pancreas and a very narrow main duct, and who still make some insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a tumor in your pancreas, bile duct, duodenum, or nearby area.
- Your pancreas is soft and your main pancreatic duct is very narrow (2 mm or less).
- Your body is still making some insulin (measurable C-peptide level).
- You are not pregnant, actively using alcohol/drugs, or have serious mental health issues that would interfere.
- You do not already have diabetes with no insulin production, and you don't have a major blood clot or high blood pressure in your liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing the entire pancreas (total pancreatectomy) versus removing only the head (standard Whipple) for certain cancers of the pancreas, bile duct, or ampulla. It is for people whose surgeon thinks the pancreas connection after surgery is likely to leak, which can cause serious complications.
This trial tests a specific surgical method called mesopancreatic excision during Whipple surgery for pancreatic cancer. It may help remove more cancer tissue and improve outcomes for patients with resectable disease.
This trial tests a two-part surgery: removing the pancreas and then putting the patient’s own insulin-making cells back into the body to help control long-term pancreatitis pain. It is aimed at adults with severe, long-lasting pain who have not improved with medicines or procedures.
This Phase 3 trial studies a pancreatic surgery approach (pylorus-preserving Whipple or similar) and, in some cases, moving your insulin-making cells into your body to help prevent a dangerous post-surgery leak from the pancreas. It may help people who are considered high risk for this complication based on pancreas texture and duct size.
This Phase 1/2 study tests whether adding an islet (insulin-producing cell) transplant at the time of pancreatic-region surgery is safe and helps prevent a serious surgical complication called a postoperative fistula. It is for people whose surgery is considered high risk for developing that complication.
This study looks at outcomes after a procedure called TPIAT (total pancreatectomy with islet auto-transplantation), which aims to improve insulin function and blood-sugar control. It may help doctors better understand how people do over time after the procedure.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.